#286 ‒ Journal club with Andrew Huberman: the impact of light exposure on mental health and an immunotherapy breakthrough for cancer treatment
The Peter Attia Drive View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Andrew Huberman, professor of neurobiology at Stanford University and host of the Huberman Lab podcast, returns for another special journal club episode. Andrew introduces an observational study investigating the influence of light exposure on circadian clock regulation and its link to mental health, while Peter covers a phase III clinical trial employing immune checkpoint inhibitors for the treatment of metastatic cancer. They delve into the essential findings of their respective papers, elucidate the reasons for their enthusiasm, and tackle potential limitations and unanswered questions. Additionally, they provide valuable insights into their approaches f
0
(-)
Rate this episode:
Episode mentions
You can listen to this podcast, but not everything mentioned in it has been defined yet. Upvote it if you want it to be added next - the most voted podcasts will be added as soon as possible
Transcript
This episode has not been transcribed yet. Upvote it if you want it to be added next - the most voted podcasts will be added as soon as possible.